Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 8, Issue 1, 2005, Pages 63-73

  Cook, Casey N ^a   Hejna, Matthew J ^a   Magnuson, Debra J ^a   Lee, John M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Alzheimer's disease; Amyloid ; Calcineurin; Calcipressin; Oxidative stress; Tau

Indexed keywords

CALCINEURIN; CALCIPRESSIN 1; PHOSPHATASE; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN NERVE CELL; CELL ACTIVITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; TEMPORAL CORTEX; TEMPORAL LOBE;

EID: 24644499539     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2005-8108     Document Type: Article

References (40)

1. C. Behl, J.B. Davis, R. Lesley and D. Schubert, Hydrogen peroxide mediates amyloid β protein toxicity, Cell 77 (1994), 817-827.
2. D.A. Butterfield, J. Drake, C. Pocernich and A. Castegna, Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide, Trends Mol Med 7 (2001), 548-558.
3. L.M. Callahan, W.A. Vaules and P.D. Coleman, Progressive reduction of synaptophysin message in single neurons in Alzheimer's disease, J Neuropathol Exp Neurol 61 (2002), 384-395.
4. L.M. Callahan, W.A. Vaules and P.D. Coleman, Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer's disease neurons containing neurofibrillary tangles, J Neuropathol Exp Neurol 58 (1999), 275-287.
5. K.T. Chang, Y.J. Shi and K.T. Min, The drosophila homolog of Down's syndrome critical region 1 gene regulates learning: implications for mental retardation, PNAS 100 (2003), 15794-15799.
6. D.R. Crawford, K.P. Leahy, N. Abramova, L. Lan, Y. Wang and K.J.A. Davies, Hamster adapt78 mRNA is a down syndrome critical region homologue that is inducible by oxidative stress, Arch Biochem Biophys 342 (1997), 6-12.
7. G. Ermak, C.D. Harris and K.J.A. Davies, The DSCR1 (adapt78) isoform1 protein calcipressin1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress, FASEB J 16 (2002), 814-824.
8. G. Ermak, T.E. Morgan and K.J.A. Davies, Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease, J Bio Chem 276 (2001), 38787-38794.
9. A. Ferrari, F. Hoerndli, T. Baechi, R.M. Nitsch and J. Gotz, β-Amyloid induces paired helical filament-like tau filaments in tissue culture, J Bio Chem 278 (2003), 40162-40168.
10. J.J. Fuentes, L. Genesca, T.J. Kingsbury, K.W. Cunningham, M. Perez-Riba, X. Estivill and S. de la Luna, DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways, Hum Mol Genet 9 (2000), 1681-1690.
11. J.J. Fuentes, M.A. Pritchard, A.M. Planas, A. Bosch, I. Ferrer and X. Estivill, A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart, Hum Mol Genet 4 (1995), 1935-1944.
12. L. Genesca, A. Aubareda, J.J. Fuentes, X. Estivill, S. de la Luna and M. Perez-Riba, Phosphorylation of calcipressin1 increases its ability to inhibit calcineurin and decreases calcipressin half-life, J Biochem 374 (2003), 567-575.
13. J. Gorlach, D.S. Fox, N.S. Cutler, G.M. Cox, J.R. Perfect and J. Heitman, Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans, J EMBO 19 (2000), 3618-3629.
14. J. Gotz, F. Chen, J. van Dorpe and R.M. Nitsch, Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils, Science 293 (2001), 1491-1495.
15. L.A. Hansen, S.E. Daniel, G.K. Wilcock and S. Love, Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia, J Neurol Neurosurg Psychiatry 64 (1998), 653-656.
16. J.M. Heffernan, S.L. Eastwood, Z. Nagy, M.W. Sanders, B. McDonald and P.J. Harrison, Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia, Exp Neurol 150 (1998), 235-239.
17. O. Heinonen, H. Soininen, H. Sorvari, O. Kosunen, L. Paljarvi, E. Koivisto and P.J. Riekkinen Sr., Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease, Neuroscience 64 (1995), 375-384.
18. B.A. Hesser, X.H. Liang, G. Camenisch, S. Yang, D.A. Lewin, R. Scheller, N. Ferrara and H.P. Gerber, Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells, Blood 104 (2004), 149-158.
19. S. Kins, A. Crameri, D.R.H. Evans, B.A. Hemmings, R.M. Nitsch and J. Gotz, Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice, J Bio Chem 276 (2001), 38193-38200.
20. K.P. Leahy and D.R. Crawford, adapt78 protects cells against stress damage and suppresses cell growth, Arch Biochem Biophys 379 (2000), 221-228.
21. K.P. Leahy, K.J.A. Davies, M. Dull, J.J. Kort, K.W. Lawrence and D.R. Craword, adapt78, a stress-inducible mRNA, is related to the glucose-regulated protein family of genes, Arch Biochem Biophys 368 (1999), 67-74.
22. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton and E. McGowan, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science 293 (2001), 1487-1491.
23. Q. Lian, C.J. Ladner, D. Magnuson and J.M. Lee, Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex, Exp Neurol 167 (2001), 158-165.
24. F. Liu, K. Iqbal, I. Grundke-Iqbal, S. Rossie and C.X. Gong, Dephosphorylation of tau by protein phosphatase 5, J Bio Chem 280 (2005), 1790-1796.
25. H. Ma, H. Xiong, T. Liu, L. Zhang, A. Godzik and Z. Zhang, Aggregate formation and synaptic abnormality induced by DSCR1, J Neurochem 88 (2004), 1485-1496.
26. R.N. Martins, C.G. Harper, G.B. Stokes and C.L. Masters, Increased cerebral glucose 6-phosphate dehydrogenase activity in AD may reflect oxidative stress, J Neurochem 46 (1986), 1042-1045.
27. M.P. Mattson, Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease, J NeuroVirology 8 (2002), 539-550.
28. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, Vogel, J.P. Hughes, G. van Belle and L. Berg, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology 41 (1991), 479-486.
29. G. Multhaup, C.L. Masters and K. Beyreuther, Oxidative stress in Alzheimer's disease, Alzheimer's Rep 1 (1998), 147-154.
30. S.C. Pfister, G.M. Machado-Santelli, S.W. Han and F. Henrique-Silva, Mutational analyses of the signals involved in the subcellular location of DSCR1, BMC Cell Bio 3 (2002), 24-31.
31. R.H. Reeves, L.L. Baxter and J.T. Richtsmeier, Too much of a good thing: mechanisms of gene action in Down syndrome, Trends Genet 17 (2001), 83-88.
32. E. Rooij, P.A. Doevandans, H. Crijns, S. Heeneman, D.J. Lips, M. Bilsen, R.S. Williams, E.N. Olson, R. Bassel-Duby, B.A. Rothermel and L.J. de Windt, MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction, Circ Res 94 (2004), e18-e26.
33. B. Rothermel, R.B. Vega, J. Yang, H. Wu, R. Bassel-Duby and R.S. Williams, A protein encoded within the down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling, J Bio Chem 275 (2000), 8719-8725.
34. S. Ryeom, R.J. Greenwald, A.M. Sharpe and F. McKeon, The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin, Nature Immunol 4 (2003), 874-881.
35. F. Shibasaki, E.R. Price, D. Milan and F. McKeon, Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4, Nature 382 (1996), 370-373.
36. H.C.S. Silveira, C.A. Sommer, A. Soares-Costa and F. Henrique-Silva, A calcineurin inhibitory protein overexpressed in Down's syndrome interacts with the product of a ubiquitously expressed transcript, Braz J Med Bio Res 37 (2004), 785-789.
37. W. Sun, H.Y. Qureshi, P.W. Cafferty, K. Sobue, A. Agarwal-Mawal, K.D. Neufield and H.K. Paudel, Glycogen synthase kinase 3β is complexed with tau protein in brain microtubules, J Bio Chem 277 (2002), 11933-11940.
38. R.B. Vega, J. Yang, B.A. Rothermel, R. Bassel-Duby and R.S. Williams, Multiple domains of MCIP1 contribute to inhibition of calcineurin activity, J Bio Chem 277 (2002), 30401-30407.
39. K.A. Walsh, J.F. Megyesi, J.X. Wilson, J. Crukley, V.E. Laubach and R.R. Hammond, Antioxidant protection from HIV1 gp120-induced neuroglial toxicity, J Neuroinflammation 8 (2004), http://www.jneuroinflammation.com/content/1/1/8.
40. J.Z. Wang, C.X. Gong, T. Zaidi, I. Grundke-Iqbal and K. Iqbal, Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B, Am Soc Biochem & Mol Bio Inc 270 (1995), 4854-4860.